TITAN 2.800 € (-10,83 %)
EXOSENS 63.550 € (-1,24 %)
VIRIDIEN 117.700 € (-1,42 %)
TONNER DRONES 0.036 € (+2,86 %)
SOGECLAIR 36.900 € (0,00 %)
FDJ UNITED 22.860 € (-0,52 %)
LOUIS HACHETTE 1.570 € (-4,85 %)
AYVENS 11.270 € (-1,14 %)
B.COM.PORTUGUES 0.931 € (+1,24 %)
AMOEBA 0.884 € (+1,03 %)
SCHNEIDER ELECTRIC 284.700 € (+0,71 %)
STELLANTIS NV 6.510 € (+0,53 %)
HERMES INTL 1 707.000 € (+2,12 %)
AIR LIQUIDE 177.580 € (-1,50 %)
AIRBUS 186.400 € (-1,11 %)
ADP 109.300 € (+1,02 %)
AIR FRANCE -KLM 10.595 € (+2,81 %)
SCOR SE 31.380 € (-0,63 %)
FIGEAC AERO 11.300 € (+1,80 %)
ORANGE 17.890 € (-1,27 %)
ARCELORMITTAL SA 54.340 € (+1,46 %)
PROSUS 42.415 € (+1,28 %)
SODEXO 43.680 € (-1,36 %)
VALNEVA 2.380 € (+2,67 %)
AHOLD DEL 37.650 € (-2,16 %)
GTT 210.200 € (-0,19 %)
TOTALENERGIES 75.700 € (-1,37 %)
DSM FIRMENICH AG 66.420 € (-2,89 %)
AXA 41.540 € (-0,62 %)
PUBLICIS GROUPE SA 81.020 € (-0,81 %)
KERING 250.000 € (+2,77 %)
PARROT 9.560 € (-3,43 %)
EDP RENOVAVEIS 14.190 € (-1,46 %)
CREDIT AGRICOLE 17.325 € (+0,43 %)
CARREFOUR 17.135 € (-0,03 %)
LVMH 481.050 € (+1,49 %)
STMICROELECTRONICS 48.930 € (+0,89 %)
MAGNUM 12.570 € (-2,68 %)
SARTORIUS STED BIO 164.600 € (-1,56 %)
EUROFINS SCIENT. 59.880 € (-0,20 %)
EDP 4.438 € (+2,00 %)
MEDINCELL 26.620 € (+0,38 %)
KPN KON 4.563 € (-0,96 %)
SANOFI 73.480 € (-1,55 %)
VALEO 11.595 € (+1,80 %)
BOUYGUES 51.420 € (-2,98 %)
RENAULT 31.270 € (+1,86 %)
DANONE 63.580 € (-2,06 %)
EURAZEO 48.840 € (+0,45 %)
AVANTIUM 8.230 € (-6,90 %)
SAFRAN 297.800 € (+0,37 %)
ALFEN 12.600 € (+1,78 %)
ELIS 27.800 € (+0,72 %)
DRONE VOLT 0.484 € (-1,18 %)
ESSILORLUXOTTICA 177.200 € (+0,28 %)
LACROIX GROUP 13.400 € (+1,90 %)
SAINT GOBAIN 81.020 € (+0,97 %)
LDC 114.800 € (+0,88 %)
BE SEMICONDUCTOR 260.900 € (+2,31 %)
NN GROUP 75.740 € (+0,05 %) |
16/04/2026 15:55
TripSitter Announces Director ResignationNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / April 16, 2026 / TripSitter Clinic Ltd. (the "Company" or "TripSitter") (CSE:KETA) announces that Matthew Morgan has resigned as a director of the Company, effective April 15, 2026. The Company would like to thank Mr. Morgan for his service to the Company and wishes him the best in his future endeavours. The Company intends to appoint a new director to replace Mr. Morgan. For more information, please contact: TripSitter Clinic Ltd. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release. CAUTIONARY DISCLAIMER STATEMENT This news release may include certain "forward-looking statements" under applicable Canadian securities legislation, including with respect to the business objectives of the Company. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties, and uncertain capital markets. Readers are cautioned that actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. SOURCE: TripSitter Clinic Ltd. View the original press release on ACCESS Newswire Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière